Log in to search using one of your social media accounts:


Esperion's cholesterol drug succeeds in late-stage study

(Reuters) - Esperion Therapeutics Inc said on Wednesday a late-stage trial of its experimental oral drug met the main goal of reducing cholesterol by 28 percent in patients suffering from, or at a high risk of, an artery-clogging heart disease.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news

Related Links:

More News: Cardiology | Cholesterol | Health | Heart | Heart Disease | Study